×
Performant Healthcare Net Profit Margin 2011-2024 | PHLT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Performant Healthcare net profit margin from 2011 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Performant Healthcare Net Profit Margin 2011-2024 | PHLT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Performant Healthcare net profit margin from 2011 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$89.4B
Cencora (COR)
$46.8B
DiDi Global (DIDIY)
$22.8B
Natera (NTRA)
$20.9B
ICON (ICLR)
$16.3B
Avantor (AVTR)
$15B
Revvity (RVTY)
$14.4B
BioMerieux (BMXMF)
$13.8B
Viatris (VTRS)
$13.5B
Solventum (SOLV)
$12.7B
CochLear (CHEOY)
$12.3B
Medpace Holdings (MEDP)
$10.5B
Doximity (DOCS)
$10B
EUROFINS SCIENT (ERFSF)
$9.6B
HealthEquity (HQY)
$8.9B
Charles River Laboratories (CRL)
$8.4B
Sonic Healthcare (SKHHY)
$8.2B
Amplifon S.p.A (AMFPF)
$6.1B
Bausch + Lomb (BLCO)
$6.1B
Organon (OGN)
$4.1B
Sotera Health (SHC)
$3.7B
BrightSpring Health Services (BTSG)
$3.2B
Alignment Healthcare (ALHC)
$2.8B
Concentras Parent (CON)
$2.7B
Surgery Partners (SGRY)
$2.6B
Premier (PINC)
$2.2B
PACS (PACS)
$2.1B
Ardent Health Partners (ARDT)
$2B
GeneDx Holdings (WGS)
$1.9B
Progyny (PGNY)
$1.8B